Shareholders in honey biotech firm TRG Natural Pharmaceuticals are searching for answers as the company’s founder and second-largest investor tries to have the firm liquidated.
A notice that appeared in theGazetteon December 3 said Shaun Holt had applied to have liquidators appointed to the
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
